Concepedia

Susan O’Brien

SO

18

Publications

2.9K

Citations

16

H-Index

1991

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The Ohio State University

Leukemia Research Foundation

Susan O’Brien is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

Top concepts

Publications per year

1991–2018

18

Publications

18

Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia

William G. Wierda, Susan O’Brien, Sijin Wen et al. · Journal of Clinical Oncology · 2005 · 521 citations

CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia

Sherif Ibrahim, Michael J. Keating, Kim‐Anh Do et al. · Blood · 2001 · 449 citations · Full text

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Hagop M. Kantarjian, Deborah A. Thomas, Jeffrey L. Jorgensen et al. · The Lancet Oncology · 2012 · 410 citations

, , +12

Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience

Susan O’Brien, Richard R. Furman, Steven Coutré et al. · Blood · 2018 · 368 citations · Full text

Chronic Myelogenous Leukemia

Susan O’Brien, Ellin Berman, Hossein Borghaei et al. · Journal of the National Comprehensive Cancer Network · 2009 · 209 citations · Full text

Rows per page

1–5 of 18